Edrecolomab
依决洛单抗
Report date: 2023/04/21 14:01:15
Base Information
Drug NameEdrecolomab
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcJohnson & JohnsonAjinomoto Co Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Cancer Institute
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksWikipedia